These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 37268322)
1. Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment. Jerome S; Farrell MB; Warren J; Embry-Dierson M; Schockling EJ J Nucl Med Technol; 2023 Jun; 51(2):102-116. PubMed ID: 37268322 [TBL] [Abstract][Full Text] [Related]
2. Cardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition. Embry-Dierson M; Farrell MB; Schockling E; Warren J; Jerome S J Nucl Med Technol; 2023 Jun; 51(2):83-89. PubMed ID: 37268319 [TBL] [Abstract][Full Text] [Related]
3. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]
4. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849 [TBL] [Abstract][Full Text] [Related]
6. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis. Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152 [TBL] [Abstract][Full Text] [Related]
8. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204 [TBL] [Abstract][Full Text] [Related]
9. Deep Learning-Enabled Quantification of Miller RJH; Shanbhag A; Michalowska AM; Kavanagh P; Liang JX; Builoff V; Fine NM; Dey D; Berman DS; Slomka PJ J Nucl Med; 2024 Jul; 65(7):1144-1150. PubMed ID: 38724278 [TBL] [Abstract][Full Text] [Related]
10. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490 [TBL] [Abstract][Full Text] [Related]
11. Inter-observer reproducibility and intra-observer repeatability in Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247 [TBL] [Abstract][Full Text] [Related]
12. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Stats MA; Stone JR Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499 [TBL] [Abstract][Full Text] [Related]
13. Updates in Cardiac Amyloidosis Diagnosis and Treatment. Stern LK; Kittleson MM Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199 [TBL] [Abstract][Full Text] [Related]
14. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction. Chen W; Ton VK; Dilsizian V Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480 [TBL] [Abstract][Full Text] [Related]